Angiotensin-Converting Enzyme Inhibitor (ACEI)-Induced Angioedema After Re-exposure to Lisinopril: A Case Report and Clinical Review

再次服用赖诺普利后发生血管紧张素转换酶抑制剂(ACEI)诱发的血管性水肿:病例报告及临床回顾

阅读:1

Abstract

Angiotensin-converting enzyme inhibitor (ACEI)-induced angioedema is an uncommon but potentially life-threatening adverse effect that can occur unpredictably, even after prolonged use. Prompt recognition and appropriate management are essential. We present the case of a 54-year-old Caucasian male with a history of ACEI-induced angioedema who developed isolated lingual swelling after re-exposure to lisinopril. His symptoms were unresponsive to antihistamines, corticosteroids, and epinephrine but resolved with supportive care following ACEI discontinuation. This case underscores the risk of recurrent angioedema following ACEI re-exposure and reinforces the recommendation for lifelong avoidance of ACEIs in patients with a prior diagnosis of ACEI-induced angioedema. Angiotensin receptor blockers (ARBs), which carry a lower risk of angioedema, may serve as preferred alternatives in high-risk patients. Patient education remains critical to preventing recurrence.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。